Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK/ERK signaling
- Yi-Ching Chen†1,
- Yin-Jing Tien†2,
- Chun-Houh Chen2,
- Francesca N Beltran3,
- Evangeline C Amor3,
- Ran-Juh Wang4,
- Den-Jen Wu4,
- Clément Mettling5,
- Yea-Lih Lin5 and
- Wen-Chin Yang1, 6, 7, 8Email author
© Chen et al.; licensee BioMed Central Ltd. 2013
Received: 10 November 2012
Accepted: 12 February 2013
Published: 23 February 2013
Morus alba has long been used in traditional Chinese medicine to treat inflammatory diseases; however, the scientific basis for such usage and the mechanism of action are not well understood. This study investigated the action of M. alba on leukocyte migration, one key step in inflammation.
Gas chromatography-mass spectrometry (GC-MS) and cluster analyses of supercritical CO2 extracts of three Morus species were performed for chemotaxonomy-aided plant authentication. Phytochemistry and CXCR4-mediated chemotaxis assays were used to characterize the chemical and biological properties of M. alba and its active compound, oxyresveratrol. fluorescence-activated cell sorting (FACS) and Western blot analyses were conducted to determine the mode of action of oxyresveratrol.
Chemotaxonomy was used to help authenticate M. alba. Chemotaxis-based isolation identified oxyresveratrol as an active component in M. alba. Phytochemical and chemotaxis assays showed that the crude extract, ethyl acetate fraction and oxyresveratrol from M. alba suppressed cell migration of Jurkat T cells in response to SDF-1. Mechanistic study indicated that oxyresveratrol diminished CXCR4-mediated T-cell migration via inhibition of the MEK/ERK signaling cascade.
A combination of GC-MS and cluster analysis techniques are applicable for authentication of the Morus species. Anti-inflammatory benefits of M. alba and its active compound, oxyresveratrol, may involve the inhibition of CXCR-4-mediated chemotaxis and MEK/ERK pathway in T and other immune cells.
KeywordsChemotaxis CXCR4 Morus Phytochemistry and T-cells
The genus Morus from the Moraceae family consists of 10–16 species of deciduous trees that are distributed worldwide . Different parts of the Morus plants such as leaves, fruit, branches, bark, root, and shoot have been used as food and herbal medicine in China for over 1900 years . In Taiwan, M. alba, commonly known as white mulberry, is possibly the Morus species most frequently used in traditional Chinese medicine although it is sometimes used interchangeably with M. atropurpurea and M. bombycis. As all three species have similar morphological characteristics and habitat preferences they are frequently misidentified. M. alba, the most extensively studied species, has been reported to have anti-hyperlipidemic , anti-hypertensive [4, 5], anti-hyperglycemic [2, 6]; Hansawasdi, 2006; , anti-microbial [8–12], anti-allergic , anti-inflammatory [14, 15], hepatoprotective [16, 17], neuroprotective , immuno-modulatory , and anti-venom activities .
Photochemical studies have identified alkaloids, flavonoids, flavones, flavanones, stilbenes, benzophenones, coumarin derivatives and terpenoids in Morus species [5, 21–37]. These compounds are likely responsible for the bioactivities of the Morus plants. Among them, the stilbenes, oxyresveratrol and resveratrol, were reported present in the Morus plants and demonstrated antioxidant activity . Oxyresveratrol inhibited nitrogen oxide (NO) production, inducible NO synthase (iNOS) expression, prostaglandin E2 (PGE2) production, and activation of nuclear factor kappa-light-chain enhancer of activated B cells (NFκB) in macrophages ; and consistently reduced edema induced by carrageenan in a mouse model . The above data suggest the involvement of oyxresveratrol in suppression of the inflammatory process. Nevertheless, the role of oxyresveratrol in the regulation of leukocyte migration has not been studied.
Migration of leucocytes from blood vessels to the flamed sites is a fundamental feature of inflammation. Chemokines and chemokine receptors can orchestrate leukocyte migration, also termed chemotaxis . In addition to its physiological functions, chemotaxis is implicated in inflammation and disease pathogenesis . Therefore, chemotaxis has been proposed as a key target of anti-inflammatory drugs . CXCR4, a G-protein-linked transmembrane receptor, is expressed in all leukocytes, blastocysts and a variety of cancer cells . SDF-1 (CXCL12) is a natural ligand of CXCR4. After binding to SDF-1, CXCR4 triggers a signaling cascade which includes the activation of kinases (FAK, PI3K, ERK, JAK, and TYK) and downstream molecules (NFκB and STAT) and, eventually regulates chemotaxis, locomotion, and adhesion .
Plants provide an extraordinary source of lead compounds for a myriad of disorders including inflammation. In this study, we investigated the role of M. alba in leukocyte migration, a key step in inflammation. As M. alba is easily misidentified due to its close resemblance to other Morus plants, we first devised a chemotaxonomic strategy involving GC-MS analysis and cluster analysis of the chemical profiles to differentiate between the Morus species. Next, the anti-chemotactic activities of M. alba and its active compound, oxyresveratrol, were examined in Jurkat T cells. Finally, the mode of action of M. alba and its active compound, oxyresveratrol, was investigated.
High performance liquid chromatography (HPLC) grade solvents, acetonitrile (ACN), dichloromethane, butanol, methanol and ethyl acetate were purchased from Avantor Performance Materials (NJ, USA). Trifluoroacetic acid (TFA), methanol, dimethyl sulfoxide (DMSO), resveratrol and oxyresveratrol were purchased from Sigmal (MO, USA). RPMI 1640 medium, PSQ solution (penicillin, streptomycin and glutamine), sodium pyruvate, non-essential amino acids and HEPES were purchased from Gibco (CA, USA). αCXCR4, FITC-conjugated secondary antibody (Life Technologies, NY, USA) and SDF-1 (R&D systems, MN, USA) were purchased. WST-1 reagent was purchased from Roche (Mannheim, Germany). Antibodies against mitogen-activated protein kinases (MAPKs) and their phosphorylated proteins were purchased from Cell Signaling Technology (MA, USA).
Supercritical liquid extraction and GC-MS analysis of plants
M. alba, M. atropurpurea and M. bombycis were collected and authenticated by Dr Ran-Juh Wang from the Miaoli District Agricultural Research and Extension Station (MDARES), Miaoli County, Taiwan, in 2010. Their voucher specimens were deposited as No. 00083241, No. 00082146, and No. 00083303, respectively, at the MDARES herbarium. Branches of the plants were air dried and pulverized. Five grams of plant samples were extracted with carbon dioxide using the supercritical fluid extractor SFX System 1220R (ISCO, NE, USA), followed by GC-MS analysis using a Trace gas chromatograph interfaced to a Polaris Q mass spectrometer (Thermo Finnigan, Hertfordshire, UK) in EI mode (70 eV) as previously described .
Extract preparation, HPLC and compound identification
Branches of Morus plants were pulverized and extracted with methanol (2 × 3 L). The methanol extracts were evaporated by rotary evaporator, yielding 1 g of crude extracts. The M. alba crude extract was re-suspended with water (150 mL), followed by sequential extraction with ethyl acetate (9 × 150 mL) and butanol (6 ×150 mL). Crude extracts, fractions, and oxyresveratrol were analyzed using an Agilent 1100 Series HPLC system. HPLC was performed on a Luna C18 column (Phenomenex, CA, USA) at a flow rate of 0.5 ml/min and 25°C with a photodiode detector at 254 nm. The solvent gradient for HPLC was set in the following sequence, 10% to 50% of B for 0–50 min, 50% of B for 50–65 min, 50 to 100% of B for 65–70 min, and 100% of B for 70 to 95 min. Solvents A and B were 0.05% TFA/H2O and 0.05% TFA/CAN, respectively. The identity of oxyresveratrol with a purity of 97% from M. alba was confirmed by comparing its spectroscopic data with previously published data [45, 46].
Chemotaxis assay and WST-1 assay
Jurkat cells E6.1 (ATCC No. TIB-152), a leukemic T cell line, were cultured in complete medium as described . The cells (1 × 106/mL) were pre-treated with crude extract, fractions, or compounds of M. alba for 24 h in 1% FBS medium. The cells were transferred into a transwell insert (Millipore, USA) and put into a 24-well plate where SDF-1 or vehicle (PBS) was added to the 1% FBS medium. After 4 h, the cells that migrated to the bottom of the 24-well plate were counted and photographed. The migration index (MI) was defined below. MI (%) = 100 × (number of drug-treated cells migrating toward SDF-1 minus number of drug-treated cells migrating toward PBS)/(number of vehicle-treated cells migrating toward SDF-1 minus number of vehicle-treated cells migrating toward PBS) . For WST-1 assay, Jurkat cells (1 × 106/mL) were incubated with the crude extract, fractions and compound for 24 h. After PBS washing, the cells were incubated with WST-1 for 1 h and measured at 440 nm using the BioTek ELISA reader (VT, USA).
Western blot and FACS analysis
Jurkat cells were pre-treated with vehicle and compounds at the indicated concentrations for 1 h. For Western blot, the cells were stimulated with SDF-1 for the indicated time. Total lysates underwent sodium dodecyl sulfate polyacrylamide gel electrophoresis and blotting with the indicated antibodies, followed by ECL visualization. To determine the CXCR4 expression level, the cells were stained with αCXCR4 and secondary antibody and underwent FACS analysis using FlowJo software.
Data from three experiments or more are presented as mean ± standard deviation. Comparisons between experimental groups and control were made using ANOVA. P values (*) less than 0.05 were considered statistically significant.
GC-MS chromatograms and cluster analysis of the chemical profiles of Morus species
By converting Figure 1C to Figure 1E using individually ranged color spectra for each retention time so that between-variant structure within each retention time (column) can be clearly depicted, we found that the combination of matrix visualization for GC-MS chemical profiles with hierarchical cluster trees using GAP was a fast and reliable chemotaxonomical method to assist in the identification of the three Morus species. In Figure 1E, the GC-MS peaks of M. alba (MAL), M. atropurpurea (MAT) and M. bombycis (MBO) are relatively larger than others with retention time in groups a, b and c, respectively. By selecting the components of groups a, b, and c in Figure 1E and significant relative peak areas in Figure 1C, we identified peaks J, G, I, and E (Figure 1C) as useful parameters to distinguish between the three species.
Overall, the combination of GC-MS and cluster tools is feasible and suitable for determining the taxonomy of the Morus species.
HPLC profiles of the three Morus plant extracts
Characterization of M. alba extract using a combination of phytochemical and chemotaxis assays
M. alba has long been used as anti-inflammatory medicine. To further understand the anti-inflammtory activity of M. alba, a chemotaxis-guided fractionation and isolation strategy was adopted (Figure 3A). HPLC analysis of the crude extract, fractions and oxyresveratrol, an active compound, of M. alba showed that oxyresveratrol (peak 1) was present in the crude extract (CE, Figure 3B) and ethyl acetate fraction (EA, Figure 3B) of M. alba; however, oxyresveratrol was not detectable in the butanol (BuOH, Figure 3B) and water (H2O, Figure 3B) fractions of M. alba.
Mechanistic study of oxyresveratrol in CXCR4-mediated chemotaxis
Next, we investigated the impact of oxyresveratrol on the CXCR4 downstream signaling molecules. MAPKs are known to function downstream of chemokine receptors ; therefore, we examined whether oxyresveratrol influenced MAPKs in the CXCR4 pathway. Western blot data showed that oxyresveratrol inhibited SDF-1-mediated phosphorylation of ERK1/2 kinases (Figure 5B). Conversely, it enhanced the SDF-1-mediated phosphorylation of p38 (Figure 5B). However, oxyresveratrol did not appear to affect SDF-1-mediated JNK phosphorylation (Figure 5B). Knowing that oxyresveratrol inhibited the activation of ERK1/2, we further examined the effect of oxyresveratrol on the upstream activators of ERK1/2 kinases, MEK1/2 kinases. Accordingly, it suppressed the phosphorylation of MEK1/2 kinases in the CXCR4 pathway (Figure 5C). These data demonstrated that oxyresveratrol in M. alba suppresses CXCR4-mediated chemotaxis via inactivation of the ERK signaling pathway. The data on Jurkat cells can be confirmed with normal leukocytes. Moreover, overall data suggest that anti-inflammatory herb, M. alba, and its oxyresveratrol suppress inflammation via inhibition of leukocyte migration involving the MEK/ERK pathway (Figure 5D).
Discussion and conclusions
Correct identification and authentication of plants are absolutely necessary for batch consistency and therapeutic efficacy of botanical medicines. M. alba is used in traditional Chinese medicine for treatment of inflammatory disorders. However, M. alba is sometimes used interchangeably with, or confused with other Morus species such as M. atropurpurea and M. bombycis. A standard method of identification of M. alba versus M. atropurpurea or M. bombycis has not been established, and the similarities/differences between the chemical and biological properties of these three species have not been studied. In this work, we first used chemotaxonomic methods to differentiate M. alba from the other two species. Spectroscopic methods were used to analyze the chemical fingerprint of crude extracts, fractions, and compounds of M. alba. Combined photochemistry and chemotaxis assays were then used for identification and anti-inflammatory study of M. alba and oxyresveratrol.
Chemokines and their receptors are involved in numerous diseases and have roles in inflammation and infection. Consequently, the antagonists and inhibitors of the chemokines and their receptors have become potential drug targets for inflammatory diseases . M. alba has been long used as anti-inflammatory remedy in China. Nevertheless, little is known about its role in leukocyte migration, a central process linked to inflammation, infection and disease pathogenesis. Here, we demonstrated that M. alba can suppress leukocyte migration triggered by CXCR4 (Figure 4). Unexpectedly, bioassay-guided isolation and identification yielded oxyresveratrol as the major active component of the bioactive ethyl acetate fraction of M. alba (Figure 3). M. alba possessed a higher abundance of oxyresveratrol than the other Morus plants (Figure 2). The evidence presented here that M. alba and its active component, oxyresveratrol, suppress CXCR4-mediated leukocyte migration supports the traditional use of M. alba as an anti-inflammatory medicine.
Oxyresveratrol has been previously reported to exert anti-inflammatory activity through inhibition of iNOS/NO production, PGE2 synthesis and NFκB activation ; and was reported to reduce carageenan-induced paw edema in rats likely through inhibition of iNOS expression . We have also observed oxyresveratrol to be a more potent inhibitor of leukocyte migration than resveratrol (Figure 4B and data not shown). Our data on the difference in chemotactic action between resveratrol and oxyresveratrol are in good agreement with a previous publication indicating that resveratrol does not inhibit chemotaxis . Thus, the OH functional group in oxyresveratrol appears to be responsible for its anti-chemotactic activity. Furthermore, oxyresveratrol inhibited the activation of the MEK/ERK pathway (Figure 5), suggesting a possible mechanism by which M. alba and oxyresveratrol inhibit inflammation.
Following engagement, chemokine receptors induce an activation of G proteins, tyrosine kinases, serine/threonine kinases and phospholipases, leading to cell migration [52, 53]. Our results showed that oxyresveratrol, isolated from M. alba, inhibited the activation of MEK/ERK kinases, a serine/threonine kinase family, mediated by CXCR4 in T-cells (Figure 5). However, oxyresveratrol did not affecte the expression level of CXCR4 receptor (Figure 4A). These findings suggest that unlike the receptor antagonists, oxyresveratrol targets the intraceullar proteins downstream of the chemokine receptors and may be used as alternative inhibitors of chemokine signaling. Consistently, MAPKs are known to modulate inflammatory responses and are thought to be attractive molecular targets for anti-inflammatory therapy . The manifestation of inactivation of MEK/ERK pathway by oxyresveratrol makes it extremely interesting potential natural anti-inflammatory remedy.
In conclusion, we combined phytochemical and chemotaxis techniques to study the anti-chemotactic role of the Morus plants. We demonstrated that M. alba and its active compound, oxyresveratrol, suppress inflammation via inhibition of leukocyte chemotaxis. Mechanistic studies showed that oxyresveratrol inhibits CXCR4-mediated leukocyte migration via inactivation of the MEK/ERK pathway downstream of the CXCR4 receptor. These findings support the claims of the benefits of M. alba purported in traditional Chinese medicine and suggest the possible use of the active compound oxyresveratrol as an anti-inflammation therapy.
Fluorescence-activated cell sorting
Gas chromatography-mass spectrometry
High performance liquid chromatography
Inducible NO synthase
Nuclear factor kappa-light-chain enhancer of activated B cells
This work was supported by the National Core Facility Program for Biotechnology, Taiwan (Bioinformatics Consortium of Taiwan, NSC100-2319-B-010-002). We thank Ms. Miranda J. Loney for English editing.
- Iqbal S, Younas U, Sirajuddin , Chan KW, Sarfraz RA, Uddin K: Proximate composition and antioxidant potential of leaves from three varieties of Mulberry (Morus sp.): a comparative study. Int J Mol Sci. 2012, 13 (6): 6651-6664.View ArticlePubMedPubMed CentralGoogle Scholar
- Singab AN, El-Beshbishy HA, Yonekawa M, Nomura T, Fukai T: Hypoglycemic effect of Egyptian Morus alba root bark extract: effect on diabetes and lipid peroxidation of streptozotocin-induced diabetic rats. J Ethnopharmacol. 2005, 100 (3): 333-338. 10.1016/j.jep.2005.03.013.View ArticlePubMedGoogle Scholar
- Dimo T, Rakotonirina S, Kamgang R, Tan PV, Kamanyi A, Bopelet M: Effects of leaf aqueous extract of Bidens pilosa (Asteraceae) on KCl- and norepinephrine-induced contractions of rat aorta. J Ethnopharmacol. 1998, 60 (2): 179-182. 10.1016/S0378-8741(97)00142-6.View ArticlePubMedGoogle Scholar
- Doi K, Kojima T, Makino M, Kimura Y, Fujimoto Y: Studies on the constituents of the leaves of Morus alba L. Chem Pharm Bull(Tokyo). 2001, 49 (2): 151-153. 10.1248/cpb.49.151.View ArticleGoogle Scholar
- Fukai T, Hano Y, Hirakura K, Nomura T, Uzawa J, Fukushima K: Structures of two natural hypotensive diels-alder type adducts, mulberrofuran F and G, from the cultivated mulberry tree (Morus lhou Koidz). Chem Pharm Bull(Tokyo). 1985, 33: 3195-3204. 10.1248/cpb.33.3195.View ArticleGoogle Scholar
- Lemus I, Garcia R, Delvillar E, Knop G: Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytother Res. 1999, 13 (2): 91-94. 10.1002/(SICI)1099-1573(199903)13:2<91::AID-PTR350>3.0.CO;2-8.View ArticlePubMedGoogle Scholar
- Katsube T, Yamasaki M, Shiwaku K, Ishijima T, Matsumoto I, Abe K, Yamasaki Y: Effect of flavonol glycoside in mulberry (Morus alba L.) leaf on glucose metabolism and oxidative stress in liver in diet-induced obese mice. J Sci Food Agric. 2010, 90 (14): 2386-2392. 10.1002/jsfa.4096.View ArticlePubMedGoogle Scholar
- Uno T, Isogai A, Suzuki A, Shirata A: Isolation and Identification of Ethyl B-Resorcylate(Ethyl2,4-Dihydroxybenzoate) and 5,7-Dihydroxychromone from the Root Bark of Mulberry Tree (Morus alba L.) and their Biological Activity. J Sericult Sci Japan. 1981, 50 (5): 422-427.Google Scholar
- Park KM, You JS, Lee HY, Baek NI, Hwang JK: Kuwanon G: an antibacterial agent from the root bark of Morus alba against oral pathogens. J Ethnopharmacol. 2003, 84 (2–3): 181-185.View ArticlePubMedGoogle Scholar
- Takasugi M, Ishikawa S, Nagao S, Masamune T: Albafuran C, a natural diels-alder adduct of a dehydroprenyl-2-phenylbenzofuran with a chalcone from mulberry. Chem Lett. 1982, 8: 1223-1224.View ArticleGoogle Scholar
- Rollinger JM, Spitaler R, Menz M, Marschall K, Zelger R, Ellmerer EP, Schneider P, Stuppner H: Venturia inaequalis-inhibiting Diels-Alder adducts from Morus root bark. J Agric Food Chem. 2006, 54 (22): 8432-8436. 10.1021/jf061871g.View ArticlePubMedGoogle Scholar
- Du J, He ZD, Jiang RW, Ye WC, Xu HX, But PP: Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry. 2003, 62 (8): 1235-1238. 10.1016/S0031-9422(02)00753-7.View ArticlePubMedGoogle Scholar
- Chai OH, Lee MS, Han EH, Kim HT, Song CH: Inhibitory effects of Morus alba on compound 48/80-induced anaphylactic reactions and anti-chicken gamma globulin IgE- mediated mast cell activation. Biol Pharm Bull. 2005, 28 (10): 1852-1858. 10.1248/bpb.28.1852.View ArticlePubMedGoogle Scholar
- Choi EM, Hwang JK: Effects of Morus alba leaf extract on the production of nitric oxide, prostaglandin E2 and cytokines in RAW264.7 macrophages. Fitoterapia. 2005, 76 (7–8): 608-613.View ArticlePubMedGoogle Scholar
- Kimura Y, Okuda H, Nomura T, Fukai T, Arichi S: Effects of flavonoids and related compounds from mulberry tree on arachidonate metabolism in rat platelet homogenates. Chem Pharm Bull(Tokyo). 1986, 34 (3): 1223-1227. 10.1248/cpb.34.1223.View ArticleGoogle Scholar
- Kalantari H, Aghel N, Bayati M: Hepatoprotective effect of Morus Alba L. in carbon tetrachloride-induced hepatotoxicity in Mice. Saudi Pharmaceut J. 2009, 17 (1): 90-94.Google Scholar
- Oh H, Ko EK, Jun JY, Oh MH, Park SU, Kang KH, Lee HS, Kim YC: Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba. Planta Med. 2002, 68 (10): 932-934. 10.1055/s-2002-34930.View ArticlePubMedGoogle Scholar
- Kang TH, Oh HR, Jung SM, Ryu JH, Park MW, Park YK, Kim SY: Enhancement of neuroprotection of mulberry leaves (Morus alba L.) prepared by the anaerobic treatment against ischemic damage. Biol Pharm Bull. 2006, 29 (2): 270-274. 10.1248/bpb.29.270.View ArticlePubMedGoogle Scholar
- Bharani SE, Asad M, Dhamanigi SS, Chandrakala GK: Immunomodulatory activity of methanolic extract of Morus alba Linn. (mulberry) leaves. Pak J Pharm Sci. 2010, 23 (1): 63-68.PubMedGoogle Scholar
- Chandrashekara KT, Nagaraju S, Nandini SU, Kemparaju K: Neutralization of local and systemic toxicity of Daboia russelii venom by Morus alba plant leaf extract. Phytother Res. 2009, 23 (8): 1082-1087. 10.1002/ptr.2735.View ArticlePubMedGoogle Scholar
- Ali A, Ali M: New triterpenoids from Morus alba L. stem bark. Nat Prod Res. 2012, 10.1080/14786419.2012.676547Google Scholar
- Kim GN, Jang HD: Flavonol content in the water extract of the mulberry (Morus alba L.) leaf and their antioxidant capacities. J Food Sci. 2011, 76 (6): C869-C873. 10.1111/j.1750-3841.2011.02262.x.View ArticlePubMedGoogle Scholar
- Nomura T, Fukai T: Kuwanon G, a new flavone derivative from the root barks of the cultivated mulberry tree (Morus alba L.). Chem Pharm Bull(Tokyo). 1980, 28 (8): 2548-2552. 10.1248/cpb.28.2548.View ArticleGoogle Scholar
- Nomura T, Fukai T, Hano Y: Constituents of the Chinese crude drug Sang-Bai-Pi (Morus Root Bark) I. structure of a new flavanone derivative, Sanggenon A.. Planta Med. 1983, 47 (1): 30-34. 10.1055/s-2007-969943.View ArticlePubMedGoogle Scholar
- Nomura T, Fukai T, Hano Y, Urano S: Constituents of the Chinese Crude Drug Sang-Bai-Pi (Morus Root Bark). Planta Med. 1983, 47 (2): 95-99. 10.1055/s-2007-969961.View ArticlePubMedGoogle Scholar
- Nomura T, Fukai T, Hano Y, Uzawa J: Structure of Sanggenon C, a natural hypotensive diels-alder adduct from Chinese Crude Drug “Sang-bái-pí” (Morus Root Bark). Heterocycles. 1981, 16 (12): 2141-2148. 10.3987/R-1981-12-2141.View ArticleGoogle Scholar
- Nomura T, Fukai T, Hano Y, Uzawa J: Structure of Sanggenon D, a Natural Hypotensive Diels-Alder Adduct from Chinese Crude Drug “Sang-bái-pí” (Morus Root Bark). Heterocycles. 1982, 17 (1): 381-389. 10.3987/S-1982-01-0381.View ArticleGoogle Scholar
- Nomura T, Fukai T, Katayanagi M: Kuwanon A, B, C and Oxydihydromorusin, four new flavones from the root bark of the cultivated mulberry tree (Morus alba L.). Chem Pharm Bull(Tokyo). 1977, 25 (3): 529-532. 10.1248/cpb.25.529.View ArticleGoogle Scholar
- Nomura T, Fukai T, Matsumoto J, Imashimizu A, Terada S, Hama M: Constituents of the cultivated mulberry tree. Planta Med. 1982, 46 (11): 167-174. 10.1055/s-2007-970044.View ArticlePubMedGoogle Scholar
- Nomura T, Fukai T, Narita T: Hypotensive constituent, Kuwanon H, a new flavone derivative from the root bark of the cultivated mylberry tree (Morus alba L.). Heterocycles. 1980, 14 (12): 1943-1951. 10.3987/R-1980-12-1943.View ArticleGoogle Scholar
- Nomura T, Fukai T, Uno J, Arai T: Mulberrofuran A, a new isoprenoid 2-Arylbenzofuran from the root bark of the cultivated mulberry tree (Morus alba L.). Heterocycles. 1978, 9 (11): 1593-1601. 10.3987/R-1978-11-1593.View ArticleGoogle Scholar
- Nomura T, Fukai T, Yamada S, Katayanagai M: Phenolic constituents of the cultivated mulberry tree (Morus alba L.). Chem Pharm Bull(Tokyo). 1976, 24 (11): 2898-2900. 10.1248/cpb.24.2898.View ArticleGoogle Scholar
- Ueda S, Matsumoto J, Nomura T: Four new natural diels-alder type adducts, Mulberrofuran E, Kuwanon Q, R, and V from Callus culture of Morus Alba L. Chem Pharm Bull(Tokyo). 1984, 32 (1): 350-353. 10.1248/cpb.32.350.View ArticleGoogle Scholar
- Ueda S, Nomura T, Fukai T, Matsumoto J: Kuwanon J, a new diels-alder adduct and chalcomoracin from callus culture of Morus Alba L. Chem Pharm Bull(Tokyo). 1982, 30 (8): 3042-3045. 10.1248/cpb.30.3042.View ArticleGoogle Scholar
- Hano Y, Fukai T, Nomura T, Uzawa J, Fukushima K: Structure of Mulberrofuran I, A Novel 2-arylbenzofura derivative from the cultivated mulberry tree (Morus bombycis Koidz.). Chem Pharm Bull(Tokyo). 1984, 32 (3): 1260-1263. 10.1248/cpb.32.1260.View ArticleGoogle Scholar
- Hano Y, Itoh M, Koyoma N, Nomura T: Constituents of the Chinese crude drug Sang-Bai-Pi (Morus Root Bark) V. structures of three new flavanones, Sanggenons L, M, and N. Heterocycles. 1984, 22 (8): 1791-1800. 10.3987/R-1984-08-1791.View ArticleGoogle Scholar
- Fukai T, Hano Y, Hirakura K, Nomura T, Uzawa J: Structure of Mulberrofuran H, A Novel 2-arylbenzofuran derivative from the cultivated mulberry tree Morus lhou (Ser.) Koidz. Chem Pharm Bull(Tokyo). 1984, 32 (2): 808-811. 10.1248/cpb.32.808.View ArticleGoogle Scholar
- Jin W, Na M, An R, Lee H, Bae K, Kang SS: Antioxidant compounds from twig of Morus alba. Nat Prod Sci. 2002, 8 (4): 129-132.Google Scholar
- Chung KO, Kim BY, Lee MH, Kim YR, Chung HY, Park JH, Moon JO: In-vitro and in-vivo anti-inflammatory effect of oxyresveratrol from Morus alba L. J Pharm Pharmacol. 2003, 55 (12): 1695-1700. 10.1211/0022357022313.View ArticlePubMedGoogle Scholar
- Barreiro O, Martin P, Gonzalez-Amaro R, Sanchez-Madrid F: Molecular cues guiding inflammatory responses. Cardiovasc Res. 2010, 86 (2): 174-182. 10.1093/cvr/cvq001.View ArticlePubMedGoogle Scholar
- Proudfoot A: Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol. 2002, 2: 106-115. 10.1038/nri722.View ArticlePubMedGoogle Scholar
- Moser B, Willimann K: Chemokines: role in inflammation and immune surveillance. Ann Rheum Dis. 2004, 63 (Suppl 2): ii84-ii89.PubMedPubMed CentralGoogle Scholar
- Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ: CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004, 35 (3): 233-245.View ArticlePubMedGoogle Scholar
- Chien SC, Young PH, Hsu YJ, Chen CH, Tien YJ, Shiu SY, Li TH, Yang CW, Marimuthu P, Tsai LF: Anti-diabetic properties of three common Bidens pilosa variants in Taiwan. Phytochemistry. 2009, 70 (10): 1246-1254. 10.1016/j.phytochem.2009.07.011.View ArticlePubMedGoogle Scholar
- Soekamtoa NH, Achmad SA, Ghisalberti EL, Hakim EH, Syah YM: Lunularin and oxyresveratrol: two stilbene derivatives from Morus macroura. Indo J Chem. 2005, 5 (3): 207-210.Google Scholar
- Djapic N, Djarmati Z, Filip S, Jankov RM: A stilbene from the heartwood of Maclura pomifera. J Serb Chem Soc. 2003, 68 (3): 235-237. 10.2298/JSC0303235D.View ArticleGoogle Scholar
- Shen MY, Liu YJ, Don MJ, Liu HY, Chen ZW, Mettling C, Corbeau P, Chiang CK, Jang YS, Li TH: Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica. PLoS One. 2011, 6 (11): e27480-10.1371/journal.pone.0027480.View ArticlePubMedPubMed CentralGoogle Scholar
- Medina-Holguin AL, Holguin FO, Micheletto S, Goehle S, Simon JA, O’Connell MA: Chemotypic variation of essential oils in the medicinal plant, Anemopsis californica. Phytochemistry. 2008, 69 (4): 919-927. 10.1016/j.phytochem.2007.11.006.View ArticlePubMedPubMed CentralGoogle Scholar
- Nyman T, Julkunen-Tiitto R: Chemical variation within and among six northern willow species. Phytochemistry. 2005, 66 (24): 2836-2843. 10.1016/j.phytochem.2005.09.040.View ArticlePubMedGoogle Scholar
- Chen CH: Generalized association plots for information visualization: the applications of the convergence of iteratively formed correlation matrices. Statistica Sinica. 2002, 12: 1-23.Google Scholar
- Tien YJ, Lee YS, Wu HM, Chen CH: Methods for simultaneously identifying coherent local clusters with smooth global patterns in gene expression profiles. BMC Bioinformatics. 2008, 9: 155-10.1186/1471-2105-9-155.View ArticlePubMedPubMed CentralGoogle Scholar
- Murdoch C, Finn A: Chemokine receptors and their role in inflammation and infectious diseases. Blood. 2000, 95 (10): 3032-3043.PubMedGoogle Scholar
- Rozengurt E: Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol. 2007, 213 (3): 589-602. 10.1002/jcp.21246.View ArticlePubMedGoogle Scholar
- Yang CL, Chik SC, Li JC, Cheung BK, Lau AS: Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages. J Med Chem. 2009, 52 (21): 6707-6715. 10.1021/jm9006164.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/45/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.